Month: October 2025

31 Oct 2025

PExA awarded SEK 1 million from Vinnova for the next step toward lung-cancer diagnostics

PExA has been awarded SEK 1,000,000 in funding from Vinnova – Sweden’s Innovation Agency – for a project that supports the company’s strategic repositioning toward future diagnostic applications. The funding is granted within the call “Deepened collaborations with the USA, the United Kingdom and Singapore in health and life science.” The project, RAISE-lung, is carried out in…

Read more
22 Oct 2025

PExA files patent application for biomarkers enabling early detection of lung cancer

PExA AB (Spotlight: PEXA) announces that the company has filed a patent application covering protein patterns for the early detection of lung cancer, based on its proprietary non-invasive airway sampling technology. Lung cancer remains the leading cause of cancer-related death worldwide, largely because the disease is typically diagnosed too late. Earlier detection could dramatically increase the chances of…

Read more

Archive

Categories